Advisor Group Holdings, Inc. Agile Therapeutics Inc Transaction History

Advisor Group Holdings, Inc.

  • $40.6 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.18 - $15.25 $36 - $3,050
-200 Reduced 17.44%
947 $0
Q2 2022

Aug 10, 2022
BUY
$1.09 - $8.24 $1,250 - $9,451
1,147 New
1,147 $1,000

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email